WCN26-3906 DAILY VAGUS NERVE STIMULATION SUPPRESSES RENAL FIBROSIS IN THE UUO MOUSE MODEL: ESTABLISHMENT OF A REMOTE-CONTROLLED OPTOGENETIC VAGUS NERVE STIMULATION SYSTEM

Read full text Summarise with VIRAT
Authors: Kotaro Shimoyama, Ryusuke Umene, Chia-Hsien Wu, Yasuna Nakamura, Tsuyoshi Inoue
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Recent studies have revealed that interactions between autonomic nervous activity and immune cells play crucial roles in both the progression and suppression of various diseases. Among these, vagus nerve stimulation (VNS) has been reported to exert organ-protective effects in multiple disease models by modulating immune cell function. The core concept underlying this neuroimmune interaction is the cholinergic anti-inflammatory pathway (CAP). When the vagus nerve is stimulated, released acetylcholine binds to nicotinic acetylcholine receptors—particularly α7nAChR—on macrophages, inducing an anti-inflammatory phenotype that suppresses inflammation and protects organs.

Fields of Study & Subjects

Vagus Nerve Stimulation Research Chronic Kidney Disease and Diabetes Cardiac Fibrosis and Remodeling

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105373–105373
Publication date
25 March 2026
Language
EN